HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Nagai Selected Research

9- deoxy- 9- chloro- 15- deoxy- 16- hydroxy- 17,17- trimethylene- 19,20- didehydroprostaglandin E2

8/2014Promotion of adipogenesis by an EP2 receptor agonist via stimulation of angiogenesis in pulmonary emphysema.
12/2009A systemically administered EP2 receptor agonist stimulates pulmonary angiogenesis in a murine model of emphysema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Nagai Research Topics

Disease

16Inflammation (Inflammations)
01/2020 - 05/2002
13Neoplasms (Cancer)
01/2022 - 03/2003
11Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2017 - 06/2004
11Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 08/2004
9Asthma (Bronchial Asthma)
03/2012 - 05/2002
8Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2002
7Neoplasm Metastasis (Metastasis)
01/2022 - 03/2003
7Alzheimer Disease (Alzheimer's Disease)
12/2021 - 12/2005
7Brain Ischemia (Cerebral Ischemia)
10/2018 - 02/2010
6Stroke (Strokes)
12/2021 - 05/2004
6Ischemia
01/2019 - 12/2007
6Overactive Urinary Bladder (Overactive Bladder)
10/2017 - 01/2008
5Lower Urinary Tract Symptoms
01/2017 - 07/2007
4Urinary Incontinence
03/2012 - 01/2009
4Metaplasia
03/2012 - 11/2002
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2012 - 04/2003
4Wounds and Injuries (Trauma)
06/2011 - 06/2002
4Lung Neoplasms (Lung Cancer)
02/2011 - 02/2004
4Emphysema
12/2009 - 12/2003
3Ischemic Stroke
12/2021 - 08/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017 - 08/2007
3Pulmonary Emphysema
01/2017 - 03/2004
3Ejaculatory Dysfunction
06/2015 - 10/2008
3Atherosclerosis
03/2015 - 02/2009
3Erectile Dysfunction
01/2014 - 12/2005
3Gender Dysphoria
01/2013 - 05/2012
3Hyperplasia
03/2012 - 11/2002
3Infections
01/2011 - 07/2002
3Pneumonia (Pneumonitis)
08/2009 - 07/2007
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2009 - 08/2003
3Fever (Fevers)
05/2008 - 07/2002
3Fibrosis (Cirrhosis)
11/2007 - 08/2003
3Disease Progression
10/2007 - 10/2005
3Neuroblastoma
01/2006 - 08/2002
2Parasitic Diseases (Parasitic Disease)
01/2022 - 03/2002
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
09/2021 - 05/2008
2Astrocytoma (Pilocytic Astrocytoma)
09/2021 - 01/2011
2Dyslipidemias (Dyslipidemia)
07/2021 - 05/2008
2Hypertension (High Blood Pressure)
01/2021 - 08/2007
2Headache (Headaches)
01/2021 - 02/2008
2Vascular Remodeling
01/2020 - 01/2011
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 04/2010
2Hypoxia (Hypoxemia)
01/2019 - 03/2009
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 06/2008
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 06/2009
2Insulin Resistance
07/2014 - 08/2007
2Infarction (Infarctions)
11/2013 - 04/2010
2Carcinoma (Carcinomatosis)
07/2013 - 05/2004
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
03/2012 - 04/2003
2Neuroinflammatory Diseases
03/2011 - 07/2010
2Tobacco Use Disorder (Nicotine Dependence)
11/2010 - 01/2007
2Cough
09/2010 - 07/2002

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2004
7Cystatin CIBA
09/2021 - 03/2003
7CytokinesIBA
06/2011 - 10/2002
6Therapeutic UsesIBA
01/2022 - 04/2007
6EnzymesIBA
03/2020 - 06/2002
5Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 07/2002
4Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2012
4Cysteine Proteinase InhibitorsIBA
09/2021 - 12/2005
4Glucose (Dextrose)FDA LinkGeneric
01/2017 - 08/2007
4Pancreatic Elastase (Elastase)IBA
01/2017 - 01/2006
4AntibodiesIBA
09/2013 - 05/2002
3DNA (Deoxyribonucleic Acid)IBA
03/2022 - 03/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2010
3Peptides (Polypeptides)IBA
01/2020 - 03/2007
3Amyloid (Amyloid Fibrils)IBA
01/2020 - 05/2008
3Messenger RNA (mRNA)IBA
01/2019 - 01/2008
3Phosphodiesterase 5 InhibitorsIBA
10/2017 - 12/2005
3Cholinergic Antagonists (Anticholinergics)IBA
10/2017 - 03/2007
3Testosterone (Sustanon)FDA Link
01/2017 - 01/2013
3Bronchodilator Agents (Bronchodilators)IBA
01/2017 - 01/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017 - 05/2002
3Biological ProductsIBA
12/2015 - 05/2006
3Tryptases (Tryptase)IBA
07/2015 - 06/2002
3Type A Botulinum Toxins (Botox)FDA Link
03/2012 - 08/2009
3Cysteine Proteases (Cysteine Protease)IBA
01/2011 - 03/2003
3NF-kappa B (NF-kB)IBA
01/2010 - 01/2006
3Interleukin-13IBA
01/2008 - 11/2002
3Transforming Growth Factor beta (TGF-beta)IBA
01/2008 - 04/2003
3Peptide Hydrolases (Proteases)FDA Link
05/2006 - 12/2003
2Hormones (Hormone)IBA
03/2022 - 02/2006
2PlasmalogensIBA
12/2021 - 11/2021
2TubulinIBA
01/2021 - 10/2002
29- deoxy- 9- chloro- 15- deoxy- 16- hydroxy- 17,17- trimethylene- 19,20- didehydroprostaglandin E2IBA
08/2014 - 12/2009
2Muscarinic AntagonistsIBA
01/2013 - 01/2009
2silodosinFDA Link
01/2012 - 10/2008
2NeurotoxinsIBA
01/2012 - 01/2012
2Chemokine CX3CL1IBA
03/2011 - 08/2002
2Salmeterol Xinafoate (Serevent)FDA Link
09/2010 - 01/2005
2Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
09/2010 - 03/2008

Therapy/Procedure

10Transplantation
01/2020 - 12/2007
10Therapeutics
06/2015 - 05/2002
3Brachytherapy
01/2022 - 06/2011
2Activities of Daily Living (ADL)
09/2019 - 03/2003
2Nephrectomy
05/2019 - 10/2011
2Prostatectomy (Retropubic Prostatectomy)
02/2019 - 02/2002
2Mesenchymal Stem Cell Transplantation
01/2018 - 03/2011
2Drug Therapy (Chemotherapy)
10/2012 - 09/2009
2Radiotherapy
03/2012 - 10/2009